Maternal and placental melatonin: Actions and implication for successful pregnancies

Minerva Ginecologica

Volumn 66, Issue 3, 2014, Pages 251-266

  Sagrillo Fagundes, L ^a   Soliman, A ^a   Vaillancourt, C ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

Melatonin; Placenta; Pre eclampsia; Pregnancy

Indexed keywords

MELATONIN; ANTIOXIDANT; BIOLOGICAL MARKER; MELATONIN RECEPTOR;

AMNION; AMNION FLUID; BIRTH; HOMEOSTASIS; HUMAN; OXIDATIVE STRESS; PLACENTA; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; REVIEW; ANIMAL; FEMALE; METABOLISM; PATHOPHYSIOLOGY; PREGNANCY OUTCOME;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; FEMALE; HUMANS; MELATONIN; OXIDATIVE STRESS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; RECEPTORS, MELATONIN;

EID: 84904095545     PISSN: 00264784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Axelrod J, Wurtman RJ, Snyder SH. Control of hydroxyindole o-methyltransferase activity in the rat pineal gland by environmental lighting. J Biol Chem 1965;240:949-54.
2. Hardeland R, Cardinali DP, Srinivasan V, Spence DW, Brown GM, Pandi-Perumal SR. Melatonin - A pleiotropic, orchestrating regulator molecule. Prog Neurobiol 2011;93:350-84.
3. Slominski RM, Reiter RJ, Schlabritz-Loutsevitch N, Ostrom RS, Slominski AT. Melatonin membrane receptors in peripheral tissues: distribution and functions. Mol Cell Endocrinol 2012;351:152-66.
4. Tan DX, Manchester LC, Liu X, Rosales-Corral SA, Acuna-Castroviejo D, Reiter RJ. Mitochondria and chloroplasts as the original sites of melatonin synthesis: a hypothesis related to melatonin's primary function and evolution in eukaryotes. J Pineal Res 2013;54:127-38.
5. Tan DX, Manchester LC, Hardeland R, Lopez-Burillo S, Mayo JC, Sainz RM et al. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res 2003;34:75-8.
6. Iriti M, Varoni EM, Vitalini S. Melatonin in traditional Mediterranean diets. J Pineal Res 2010;49:101-5.
7. Brzezinski A, Seibel MM, Lynch HJ, Deng MH, Wurtman RJ. Melatonin in human preovulatory follicular fluid. J Clin Endocrinol Metab 1987;64:865-7. (Pubitemid 17044561)
8. Lanoix D, Beghdadi H, Lafond J, Vaillancourt C. Human placental trophoblasts synthesize melatonin and express its receptors. J Pineal Res 2008;45:50-60. (Pubitemid 351986262)
9. Galano A, Tan DX, Reiter RJ. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011;51:1-16.
10. Dubocovich ML, Markowska M. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 2005;27:101-10. (Pubitemid 41558442)
11. Nelson CS, Ikeda M, Gompf HS, Robinson ML, Fuchs NK, Yoshioka T et al. Regulation of melatonin 1a receptor signaling and trafficking by asparagine-124. Mol Endocrinol 2001;15:1306-17. (Pubitemid 32703479)
12. Fukunaga K, Horikawa K, Shibata S, Takeuchi Y, Miyamoto E. Ca2+/calmodulin-dependent protein kinase II-dependent long-term potentiation in the rat suprachiasmatic nucleus and its inhibition by melatonin. J Neurosci Res 2002;70:799-807. (Pubitemid 35416897)
13. Fustin JM, Dardente H, Wagner GC, Carter DA, Johnston JD, Lincoln GA et al. Egr1 involvement in evening gene regulation by melatonin. FASEB journal 2009;23:764-73.
14. Olcese J, Lozier S, Paradise C. Melatonin and the circadian timing of human parturition. Reprod Sci 2013;20:168-74.
15. Radogna F, Sestili P, Martinelli C, Paolillo M, Paternoster L, Albertini MC et al. Lipoxygenase-mediated pro-radical effect of melatonin via stimulation of arachidonic acid metabolism. Toxicol Appl Pharmacol 2009;238:170-7.
16. Sewerynek E. Melatonin and the cardiovascular system. Neuro Endocrinol Lett 2002;23(Suppl 1):79-83. (Pubitemid 34495387)
17. Tomas-Zapico C, Coto-Montes A. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res 2005;39:99-104. (Pubitemid 41140746)
18. Markus RP, Cecon E, Pires-Lapa MA. Immune-Pineal Axis: Nuclear Factor kappaB (NF-kB) Mediates the Shift in the Melatonin Source from Pinealocytes to Immune Competent Cells. Int J Mol Sci 2013;14:10979-97.
19. Solar SGN, Surdhar PS. Oxidation of tryptophan and Nmethylindole by N3, Br2-, (SNC)2.- radicals in light and heavy water solutions. A pulse radiolysis study. J Phys Chem 1991;95:3639-43.
20. Tan DX, Manchester LC, Reiter RJ, Plummer BF, Hardies LJ, Weintraub ST et al. A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation. Biochem Biophys Res Commun 1998;253:614-20. (Pubitemid 29039192)
21. Stasica P, Ulanski P, Rosiak JM. Melatonin as a hydroxyl radical scavenger. J Pineal Res 1998;25:65-6. (Pubitemid 28319918)
22. Galano A, Tan DX, Reiter RJ. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res 2013;54:245-57.
23. Milczarek R, Hallmann A, Sokolowska E, Kaletha K, Klimek J. Melatonin enhances antioxidant action of alpha-tocopherol and ascorbate against NADPH- and iron-dependent lipid peroxidation in human placental mitochondria. J Pineal Res 2010;49:149-55.
24. Farmer EE, Mueller MJ. ROS-mediated lipid peroxidation and RES-activated signaling. Annu Rev Plant Biol 2013;64:429-50.
25. Cardinali DP, Pagano ES, Scacchi Bernasconi PA, Reynoso R, Scacchi P. Melatonin and mitochondrial dysfunction in the central nervous system. Horm Behav 2013;63:322-30.
26. Acuna Castroviejo D, Lopez LC, Escames G, Lopez A, Garcia JA, Reiter RJ. Melatonin-mitochondria interplay in health and disease. Curr Top Med Chem 2011;11:221-40.
27. Coto-Montes A, Boga JA, Rosales-Corral S, Fuentes-Broto L, Tan DX, Reiter RJ. Role of melatonin in the regulation of autophagy and mitophagy: a review. Mol Cell Endocrinol 2012;361:12-23.
28. Fernandes PA, Cecon E, Markus RP, Ferreira ZS. Effect of TNF-alpha on the melatonin synthetic pathway in the rat pineal gland: basis for a 'feedback' of the immune response on circadian timing. J Pineal Res 2006;41:344-50. (Pubitemid 44498220)
29. Carrillo-Vico A, Lardone PJ, Fernandez-Santos JM, Martin-Lacave I, Calvo JR, Karasek M et al. Human lymphocyte-synthesized melatonin is involved in the regulation of the interleukin-2/interleukin-2 receptor system. J Clin Endocrinol Metab 2005;90:992-1000. (Pubitemid 40279225)
30. Carrillo-Vico A, Lardone PJ, Naji L, Fernandez-Santos JM, Martin-Lacave I, Guerrero JM et al. Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects. J Pineal Res 2005;39:400-8.
31. Nakamura Y, Tamura H, Kashida S, Takayama H, Yamagata Y, Karube A et al. Changes of serum melatonin level and its relationship to feto-placental unit during pregnancy. J Pineal Res 2001;30:29-33. (Pubitemid 32056608)
32. Okatani Y, Wakatsuki A, Morioka N, Watanabe K. Melatonin inhibits the vasorelaxant action of peroxynitrite in human umbilical artery. J Pineal Res 1999;27:111-5. (Pubitemid 29440991)
33. Torres-Farfan C, Rocco V, Monso C, Valenzuela FJ, Campino C, Germain A et al. Maternal melatonin effects on clock gene expression in a nonhuman primate fetus. Endocrinology 2006;147:4618-26. (Pubitemid 44402167)
34. Itoh MT, Ishizuka B, Kuribayashi Y, Amemiya A, Sumi Y. Melatonin, its precursors, and synthesizing enzyme activities in the human ovary. Mol Hum Reprod 1999;5:402-8. (Pubitemid 29202195)
35. Niles LP, Wang J, Shen L, Lobb DK, Younglai EV. Melatonin receptor mRNA expression in human granulosa cells. Mol Cell Endocrinol 1999;156:107-10. (Pubitemid 29460749)
36. Espey LL. Current status of the hypothesis that mammalian ovulation is comparable to an inflammatory reaction. Biol Reprod 1994;50:233-8. (Pubitemid 24058476)
37. Agarwal A, Gupta S, Sharma RK. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol 2005;3:28.
38. Behrman HR, Kodaman PH, Preston SL, Gao S. Oxidative stress and the ovary. J Soc Gynecol Investig 2001;8:S40-2.
39. Tamura H, Takasaki A, Taketani T, Tanabe M, Kizuka F, Lee L et al. Melatonin as a free radical scavenger in the ovarian follicle. Endocrine Journal 2013;60:1-13.
40. Taketani T, Tamura H, Takasaki A, Lee L, Kizuka F, Tamura I et al. Protective role of melatonin in progesterone production by human luteal cells. J Pineal Res 2011;51:207-13.
41. Sugino N, Karube-Harada A, Taketani T, Sakata A, Nakamura Y. Withdrawal of ovarian steroids stimulates prostaglandin F2alpha production through nuclear factor-kappaB activation via oxygen radicals in human endometrial stromal cells: potential relevance to menstruation. J Reprod Dev 2004;50:215-25. (Pubitemid 40631821)
42. Allegra M, Reiter RJ, Tan DX, Gentile C, Tesoriere L, Livrea MA. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003;34:1-10. (Pubitemid 36140351)
43. Tamura H, Takasaki A, Miwa I, Taniguchi K, Maekawa R, Asada H et al. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res 2008;44:280-7. (Pubitemid 351392942)
44. Nakamura Y, Tamura H, Takayama H, Kato H. Increased endogenous level of melatonin in preovulatory human follicles does not directly influence progesterone production. Fertil Steril 2003;80:1012-6. (Pubitemid 37230040)
45. Tamura H, Nakamura Y, Korkmaz A, Manchester LC, Tan DX, Sugino N et al. Melatonin and the ovary: physiological and pathophysiological implications. Fertil Steril 2009;92:328-43.
46. Lindow SW, Jha RR, Thompson JW. 24 hour rhythm to the onset of preterm labour. BJOG 2000;107:1145-8.
47. Ducsay CA, Yellon SM. Photoperiod regulation of uterine activity and melatonin rhythms in the pregnant rhesus macaque. Biol Reprod 1991;44:967-74.
48. Chard T. Fetal and maternal oxytocin in human parturition. Am J Perinatol 1989;6:145-52. (Pubitemid 19122604)
49. Takayama H, Nakamura Y, Tamura H, Yamagata Y, Harada A, Nakata M et al. Pineal gland (melatonin) affects the parturition time, but not luteal function and fetal growth, in pregnant rats. Endocrine Journal 2003;50:37-43. (Pubitemid 36305845)
50. Revell VL, Skene DJ. Light-induced melatonin suppression in humans with polychromatic and monochromatic light. Chronobiol Int 2007;24:1125-37. (Pubitemid 350256128)
51. Schlabritz-Loutsevitch N, Hellner N, Middendorf R, Muller D, Olcese J. The human myometrium as a target for melatonin. J Clin Endocrinol Metab 2003;88:908-13. (Pubitemid 36207841)
52. Reiter RJ, Rosales-Corral SA, Manchester LC, Tan DX. Peripheral reproductive organ health and melatonin: ready for prime time. Int J Mol Sci 2013;14:7231-72.
53. Sharkey JT, Cable C, Olcese J. Melatonin sensitizes human myometrial cells to oxytocin in a protein kinase C alpha/extracellular-signal regulated kinase-dependent manner. J Clin Endocrinol Metab 2010;95:2902-8.
54. Kivela A, Kauppila A, Leppaluoto J, Vakkuri O. Serum and amniotic fluid melatonin during human labor. J Clin Endocrinol Metab 1989;69:1065-8. (Pubitemid 19261840)
55. Mitchell MD, Sayers L, Keirse MJ, Anderson AB, Turnbull AC. Melatonin in amniotic fluid during human parturition. Br J Obstet Gynaecol 1978;85:684-6. (Pubitemid 8388976)
56. Grishchenko VI, Demidenko DI, Koliada LD. [Dynamics of melatonin excretion in women at the end of pregnancy, during normal labor and during the postpartum period]. Akush Ginekol (Mosk) 1976;5:27-9.
57. Tamura H, Nakamura Y, Terron MP, Flores LJ, Manchester LC, Tan DX et al. Melatonin and pregnancy in the human. Reprod Toxicol 2008;25:291-303.
58. Srinivasan V, Lauterbach EC, Ho KY, Acuna-Castroviejo D, Zakaria R, Brzezinski A. Melatonin in antinociception: its therapeutic applications. Curr Neuropharmacol 2012;10:167-78.
59. Schmidt W. The amniotic fluid compartment: the fetal habitat. Adv Anat Embryol Cell Biol 1992;127:1-100.
60. Mitchell MD, Sayers L, Keirse MJNC, Anderson ABM, Turnbull AC. Melatonin in amniotic fluid during human parturition. BJOG 1978;85:684-6. (Pubitemid 8388976)
61. Reiter RJ, Tan DX, Korkmaz A, Rosales-Corral SA. Melatonin and stable circadian rhythms optimize maternal, placental and fetal physiology. Hum Reprod Update 2014;20:293-307.
62. Okatani Y, Okamoto K, Hayashi K, Wakatsuki A, Tamura S, Sagara Y. Maternal-fetal transfer of melatonin in pregnant women near term. J Pineal Res 1998;25:129-34. (Pubitemid 28430591)
63. Xu DX, Wang H, Ning H, Zhao L, Chen YH. Maternally administered melatonin differentially regulates lipopolysaccharide-induced proinflammatory and anti-inflammatory cytokines in maternal serum, amniotic fluid, fetal liver, and fetal brain. J Pineal Res 2007;43:74-9. (Pubitemid 47035224)
64. Kaneko Y, Hayashi T, Yu S, Tajiri N, Bae EC, Solomita MA et al. Human amniotic epithelial cells express melatonin receptor MT1, but not melatonin receptor MT2: a new perspective to neuroprotection. J Pineal Res 2011;50:272-80.
65. Ciesla W. Low ACTH and high melatonin concentrations in amniotic fluid as hormonal markers of high risk of fetal abnormalities. Preliminary studies. Prenat Diagn 1998;18:980-3. (Pubitemid 28438853)
66. Longtine MS, Nelson DM. Placental dysfunction and fetal programming: the importance of placental size, shape, histopathology, and molecular composition. Semin Reprod Med 2011;29:187-96.
67. Desforges M, Sibley CP. Placental nutrient supply and fetal growth. Int J Dev Biol 2010;54:377-90.
68. Vaillancourt C, Lanoix D, Le Bellego F, Daoud G, Lafond J. Involvement of MAPK signalling in human villous trophoblast differentiation. Mini Rev Med Chem 2009;9:962-73.
69. Burton GJ, Jauniaux E. Oxidative stress. Best Pract Res Clin Obstet Gynaecol 2011;25:287-99.
70. Lanoix D LJVC. Placental disorders in preeclampsia: maternal and perinatal outcomes. In: Pregnancy disorders and perinatal outcomes. Sharjah: Bentham Science Publishers; 2012. p. 97-128.
71. Zeldovich VB, Robbins JR, Kapidzic M, Lauer P, Bakardjiev AI. Invasive extravillous trophoblasts restrict intracellular growth and spread of listeria monocytogenes. PLoS Pathogens 2011;7:e1002005.
72. Iwasaki S, Nakazawa K, Sakai J, Kometani K, Iwashita M, Yoshimura Y et al. Melatonin as a local regulator of human placental function. J Pineal Res 2005;39:261-5. (Pubitemid 41337806)
73. Lanoix D, Ouellette R, Vaillancourt C. Expression of melatoninergic receptors in human placental choriocarcinoma cell lines. Hum Reprod 2006;21:1981-9. (Pubitemid 44288070)
74. Nakazawa K, Kanakura Y, Kometani K, Iwasaki S, Yosimura Y. Study on melatonin in human and rat placental tissue. Placenta 1999;20(Suppl. 1):467-74.
75. Lanoix D, Lacasse AA, Reiter RJ, Vaillancourt C. Melatonin: the watchdog of villous trophoblast homeostasis against hypoxia/reoxygenation-induced oxidative stress and apoptosis. Mol Cell Endocrinol 2013;381:35-45.
76. Lanoix D, Lacasse AA, Reiter RJ, Vaillancourt C. Melatonin: the smart killer: the human trophoblast as a model. Mol Cell Endocrinol 2012;348:1-11.
77. Frendo JL, Therond P, Bird T, Massin N, Muller F, Guibourdenche J et al. Overexpression of copper zinc superoxide dismutase impairs human trophoblast cell fusion and differentiation. Endocrinology 2001;142:3638-48. (Pubitemid 32681775)
78. Lanoix D, Lacasse A-A, Reiter RJ, Vaillancourt C. Melatonin: The smart killer: The human trophoblast as a model. Mol Cell Endocrinol 2012;348:1-11.
79. Roberts JM, Hubei CA. The two stage model of preeclampsia: variations on the theme. Placenta 2009;30(Suppl A):S32-7.
80. Lanoix D, Guerin P, Vaillancourt C. Placental melatonin production and melatonin receptor expression are altered in preeclampsia: new insights into the role of this hormone in pregnancy. J Pineal Res 2012;53:417-25.
81. Yamamoto Dde R, Yamamoto Lde R, Rocha LP, Machado JR, Guimaraes CS, Reis MA et al. Increase of placental sensitivity to melatonin and the alteration to its local synthesis in hypertensive syndromes in pregnancy. Hypertens Pregnancy 2013;32:120-8.
82. Narayan KMV. Diabetes public health: from data to policy. Oxford: Oxford University Press; 2011. p. xxi-ii, 802.
83. Zhang C, Bao W, Rong Y, Yang H, Bowers K, Yeung E et al. Genetic variants and the risk of gestational diabetes mellitus: a systematic review. Hum Reprod Update 2013;19:376-90.
84. Xiang AH, Kjos SL, Takayanagi M, Trigo E, Buchanan TA. Detailed physiological characterization of the development of type 2 diabetes in Hispanic women with prior gestational diabetes mellitus. Diabetes 2010;59:2625-30.
85. Kim JY, Cheong HS, Park BL, Baik SH, Park S, Lee SW et al. Melatonin receptor 1 B polymorphisms associated with the risk of gestational diabetes mellitus. BMC Med Genet 2011;12:82.
86. Korkmaz A, Ma S, Topal T, Rosales-Corral S, Tan DX, Reiter RJ. Glucose: a vital toxin and potential utility of melatonin in protecting against the diabetic state. Mol Cell Endocrinol 2012;349:128-37.
87. Heazell AE, Lacey HA, Jones CJ, Huppertz B, Baker PN, Crocker IP. Effects of oxygen on cell turnover and expression of regulators of apoptosis in human placental trophoblast. Placenta 2008;29:175-86.
88. Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod 2003;69:1-7. (Pubitemid 36806800)
89. Lemley CO, Meyer AM, Camacho LE, Neville TL, Newman DJ, Caton JS et al. Melatonin supplementation alters uteroplacental hemodynamics and fetal development in an ovine model of intrauterine growth restriction. Am J Physiol Regul Integr Comp Physiol 2012;302:R454-67.
90. Lemley CO, Camacho LE, Vonnahme KA. Uterine infusion of melatonin or melatonin receptor antagonist alters ovine feto-placental hemodynamics during midgestation. Biol Reprod 2013;89:40.
91. Miller SL, Yawno T, Alers NO, Castillo-Melendez M, Supramaniam VG, Vanzyl N et al. Antenatal antioxidant treatment with melatonin to decrease newborn neurodevelopmental deficits and brain injury caused by fetal growth restriction. J Pineal Res 2014;56:283-94.
92. Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH, Vitamins in pre-eclampsia trial C. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet 2006;367:1145-54.
93. Nordlund JJ, Lerner AB. The effects of oral melatonin on skin color and on the release of pituitary hormones. J Clin Endocrinol Metab 1977;45:768-74. (Pubitemid 8212527)
94. Jahnke G, Marr M, Myers C, Wilson R, Travlos G, Price C. Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Sci 1999;50:271-9. (Pubitemid 29407090)
95. Arendt J. Safety of melatonin in long-term use (?). J Biol Rhythms 1997;12:673-81.
96. Sadowsky DW, Yellon S, Mitchell MD, Nathanielsz PW. Lack of effect of melatonin on myometrial electromyographic activity in the pregnant sheep at 138-142 days gestation (term = 147 days gestation). Endocrinology 1991;128:1812-8.
97. Hobson SR, Lim R, Gardiner EE, Alers NO, Wallace EM. Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by pre-eclampsia (PAMPR): study protocol. BMJ open 2013;3:e003788.
98. Alers NO, Jenkin G, Miller SL, Wallace EM. Antenatal melatonin as an antioxidant in human pregnancies complicated by fetal growth restriction - a phase I pilot clinical trial: study protocol. BMJ open 2013;3:e004141. Canada